TY - JOUR
T1 - Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin
AU - Tedesco, Martina
AU - Giannese, Francesca
AU - Lazarević, Dejan
AU - Giansanti, Valentina
AU - Rosano, Dalia
AU - Monzani, Silvia
AU - Catalano, Irene
AU - Grassi, Elena
AU - Zanella, Eugenia R
AU - Botrugno, Oronza A
AU - Morelli, Leonardo
AU - Panina Bordignon, Paola
AU - Caravagna, Giulio
AU - Bertotti, Andrea
AU - Martino, Gianvito
AU - Aldrighetti, Luca
AU - Pasqualato, Sebastiano
AU - Trusolino, Livio
AU - Cittaro, Davide
AU - Tonon, Giovanni
N1 - © 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2022/2
Y1 - 2022/2
N2 - Recent efforts have succeeded in surveying open chromatin at the single-cell level, but high-throughput, single-cell assessment of heterochromatin and its underlying genomic determinants remains challenging. We engineered a hybrid transposase including the chromodomain (CD) of the heterochromatin protein-1α (HP-1α), which is involved in heterochromatin assembly and maintenance through its binding to trimethylation of the lysine 9 on histone 3 (H3K9me3), and developed a single-cell method, single-cell genome and epigenome by transposases sequencing (scGET-seq), that, unlike single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq), comprehensively probes both open and closed chromatin and concomitantly records the underlying genomic sequences. We tested scGET-seq in cancer-derived organoids and human-derived xenograft (PDX) models and identified genetic events and plasticity-driven mechanisms contributing to cancer drug resistance. Next, building upon the differential enrichment of closed and open chromatin, we devised a method, Chromatin Velocity, that identifies the trajectories of epigenetic modifications at the single-cell level. Chromatin Velocity uncovered paths of epigenetic reorganization during stem cell reprogramming and identified key transcription factors driving these developmental processes. scGET-seq reveals the dynamics of genomic and epigenetic landscapes underlying any cellular processes.
AB - Recent efforts have succeeded in surveying open chromatin at the single-cell level, but high-throughput, single-cell assessment of heterochromatin and its underlying genomic determinants remains challenging. We engineered a hybrid transposase including the chromodomain (CD) of the heterochromatin protein-1α (HP-1α), which is involved in heterochromatin assembly and maintenance through its binding to trimethylation of the lysine 9 on histone 3 (H3K9me3), and developed a single-cell method, single-cell genome and epigenome by transposases sequencing (scGET-seq), that, unlike single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq), comprehensively probes both open and closed chromatin and concomitantly records the underlying genomic sequences. We tested scGET-seq in cancer-derived organoids and human-derived xenograft (PDX) models and identified genetic events and plasticity-driven mechanisms contributing to cancer drug resistance. Next, building upon the differential enrichment of closed and open chromatin, we devised a method, Chromatin Velocity, that identifies the trajectories of epigenetic modifications at the single-cell level. Chromatin Velocity uncovered paths of epigenetic reorganization during stem cell reprogramming and identified key transcription factors driving these developmental processes. scGET-seq reveals the dynamics of genomic and epigenetic landscapes underlying any cellular processes.
KW - Chromatin/genetics
KW - Epigenesis, Genetic/genetics
KW - Euchromatin/genetics
KW - Heterochromatin/genetics
KW - Humans
KW - Transposases/genetics
U2 - 10.1038/s41587-021-01031-1
DO - 10.1038/s41587-021-01031-1
M3 - Article
C2 - 34635836
SN - 1546-1696
VL - 40
SP - 235
EP - 244
JO - Nat Biotechnol
JF - Nat Biotechnol
IS - 2
ER -